Phytosterols have an unfavourable effect on bacterial activity and no evident protective effect on colon carcinogenesis.
The effects of physiological dietary phytosterol supplements on intestinal microflora activity and faecal sterols and their capacity to protect rats fed a normal or high saturated fatty-acid diet against tumour development were studied. A group of 80 female Wistar rats were fed an 8% lipid diet for 4 weeks (adaptation period) and then randomly assigned in a factorial experimental design study to diets containing 8% or 24% hydrogenated coconut oil, with or without a 24-mg/day/rat phytosterol supplement. They were instilled intrarectally with saline or methyl-nitroso-urea (MNU). Faecal sterol output was analysed for one week each month. Pathological analysis was done at the end of the 30-week experiment. Animals treated with MNU and given phytosterol supplements had tumour frequencies (8/20) similar to those not fed phytosterols (11/20). The fat-supplemented diet had no significant influence. Colonic glands were found in area of lymphoid follicles in all the groups, but were more frequent in rats on high-fat diets (P < 0.01). The coprostanol and the cholesterol excretion of the phytosterol-supplemented rats was significantly enhanced. Therefore phytosterols have an unfavourable effect on bacterial activity. These data confirm the capacity of phytosterols to decrease cholesterol absorption, but indicate that a large excess of phytosterol must be avoided until further research on its effects on carcinogenesis has been done.
Quilliot
D
D
Centre de Nutrition Humaine, Université de Nancy I, France. d.quilliot@chu-nancy.fr
Boman
F
F
Creton
C
C
Pelletier
X
X
Floquet
J
J
Debry
G
G
D000818:Animals; D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000494:pharmacology; D004083:Cholestanol / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D003110:Colonic Neoplasms / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D004041:Dietary Fats / Q000009:adverse effects; D004195:Disease Models, Animal; D005243:Feces / Q000737:chemistry; D005260:Female; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology*; D010840:Phytosterols / Q000009:adverse effects* / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D016588:Anticarcinogenic Agents; D004041:Dietary Fats; D010840:Phytosterols; D004083:Cholestanol; D002784:Cholesterol